The programme is designed to support early-stage biotech companies in getting their biologic or cell & gene therapy products and technologies to market
The new platform enables researchers and patients to create "BioAgents" — autonomous AI co-scientists — to bring a faster, blockchain-verified path from lab to market
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.